State Street SPDR S&P Pharmaceuticals ETF
ETFYour view on XPH
State Street SPDR S&P Pharmaceuticals ETF
ETFSPDRSentiment
AUM (USD)
$591.91M
Expense Ratio
0.35%
Holdings
63
Sentiment
Overview for State Street SPDR S&P Pharmaceuticals ETF
- Fund Type
- ETF
- Fund Issuer
- SPDR
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- June 19, 2006
- Domicile
- US
- Fund Type
- ETF
- Fund Issuer
- SPDR
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- June 19, 2006
- Domicile
- US
- Fund Type
- ETF
- Fund Issuer
- SPDR
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- June 19, 2006
- Domicile
- US
About this fund
The State Street SPDR S&P Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index (the "Index")Seeks to provide exposure to the pharmaceuticals se…
XPH Stock Price
Key Facts
EquityExpense Ratio
0.35%
AUM
$591.91M
Fund Details
Expense Ratio
0.35%
Assets Under Management
$591.91M
NAV
$68.03 USD
Holdings
63
Average Volume
102.2K
Inception Date
June 19, 2006
Asset Class
Equity
Fund Issuer
SPDR
Domicile
US
ISIN
US78464A7220
CUSIP
78464A722
NAV Currency
USD
Expense Ratio
0.35%
Assets Under Management
$591.91M
NAV
$68.03 USD
Holdings
63
Average Volume
102.2K
Inception Date
June 19, 2006
Asset Class
Equity
Fund Issuer
SPDR
Domicile
US
ISIN
US78464A7220
CUSIP
78464A722
NAV Currency
USD
Latest headlines and company announcements for this company. Press releases and market coverage, newest first.
News
this company valued side by side against its closest peers. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.